The current PE ratio of BIO cannot be calculated, as the latest EPS of -$14.97 is negative. The most recent PE ratio recorded for Bio-Rad Laboratories was 5.3 in December 2021.
Over the last ten years, the average PE ratio of Bio-Rad Laboratories has been 62.42. Looking back at the last ten years, BIO's PE ratio peaked in the Jun 2017 quarter at 514.34, with a price of $226.31 and an EPS of $0.44. The Sep 2021 quarter marked the lowest point at 3.34, with a price of $745.95 and an EPS of $223.61.
Maximum annual increase: 458.78% in 2016
Maximum annual decrease: -72.03% in 2017
|Stock name||PE ratio||Market cap|
|GE General Electric Co||13.1||$120.48B|
|DHR Danaher Corp||28.76||$183.28B|
|A Agilent Technologies Inc||29.18||$32.7B|
|JNJ Johnson & Johnson||31.21||$404.76B|
|TMO Thermo Fisher Scientific Inc||34.55||$196.28B|
|BDX Becton Dickinson & Co||46.64||$75.23B|
|HBIO Harvard Bioscience Inc||N/A||$178.01M|
|BIO Bio-Rad Laboratories Inc||N/A||$10.43B|
The current price to earnings ratio of BIO cannot be determined, as its EPS of -$14.97 is negative.
As an average over the last 3 years, BIO stock has a PE ratio of 4.4.
As an average over the last 5 years, BIO stock has a PE ratio of 8.93.
The highest quarterly PE ratio in the last ten years has been 514.34 and it was in the Jun 2017 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.